GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.95
-0.05 (-0.28%)
Mar 24, 2026, 1:30 PM CST

TPE:3164 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5441,5781,7482,1372,0472,103
Market Cap Growth
-12.52%-9.68%-18.22%4.39%-2.67%9.23%
Enterprise Value
1,4091,4811,7062,0221,8181,937
Last Close Price
17.9518.3519.4823.3421.7821.40
PE Ratio
27.2027.5930.5264.7735.9318.59
PS Ratio
3.853.934.546.725.554.92
PB Ratio
1.061.091.181.481.371.38
P/TBV Ratio
1.161.191.301.631.521.53
P/FCF Ratio
22.0022.4921.871655.1831.11-
P/OCF Ratio
20.9821.4514.1061.7614.9418.84
EV/Sales Ratio
3.513.694.436.364.934.53
EV/EBITDA Ratio
11.3011.8815.7729.3916.5413.54
EV/EBIT Ratio
24.4025.6541.98289.2929.3415.49
EV/FCF Ratio
20.0821.1021.351565.8627.64-
Debt / Equity Ratio
0.080.080.080.040.020.02
Debt / EBITDA Ratio
0.900.901.060.810.310.22
Debt / FCF Ratio
1.591.591.4945.160.53-
Net Debt / Equity Ratio
-0.17-0.17-0.16-0.19-0.24-0.25
Net Debt / EBITDA Ratio
-2.03-2.03-2.22-3.93-3.33-2.72
Net Debt / FCF Ratio
-3.61-3.61-3.00-209.14-5.5773.63
Asset Turnover
0.240.240.230.190.220.26
Inventory Turnover
2.022.021.781.492.423.58
Quick Ratio
3.183.182.802.522.823.43
Current Ratio
4.284.283.873.183.244.17
Return on Equity (ROE)
3.28%3.28%3.26%1.52%3.14%7.29%
Return on Assets (ROA)
2.14%2.14%1.51%0.26%2.28%4.72%
Return on Invested Capital (ROIC)
3.66%3.57%2.48%0.48%3.92%8.99%
Return on Capital Employed (ROCE)
3.80%3.80%2.60%0.50%4.00%8.00%
Earnings Yield
3.70%3.62%3.28%1.54%2.78%5.38%
FCF Yield
4.55%4.45%4.57%0.06%3.21%-0.25%
Dividend Yield
4.44%-4.11%2.14%3.21%5.14%
Payout Ratio
121.00%121.00%75.56%183.26%166.75%53.42%
Buyback Yield / Dilution
0.07%0.07%-0.18%0.10%0.09%1.50%
Total Shareholder Return
4.46%0.07%3.93%2.25%3.31%6.64%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.